Cell and gene therapies are transforming the healthcare landscape, offering promising solutions for curing diseases and achieving prolonged remission. This event brings together influential stakeholders to tackle issues of access and affordability. Through active engagement and partnership, industry leaders strive to refine pricing methodologies and reimbursement frameworks to improve patient accessibility and ensure the successful introduction of therapies.
